March 2025 Life Sciences Update

08

What Makes an Emerging Market?

CONTENTS

Access to a Healthcare Ecosystem

• Healthcare providers, research institutions and universities help formulate an attractive life sciences market by providing several benefits such as:

Non-Top Tier Hospital

Top Tier Hospital SF

# of Existing Hospitals (RHS)

Collaboration and innovation.

•

40

180

A steady stream of talent.

•

160

35

Improved access to patient populations critical for clinical trials

•

140

30

• Medical professionals have direct access to patients and possess a high level of trust and credibility, which significantly boosts patient enrollment in clinical trials. This helps mitigate low patient participation, which often hinders clinical trials and delays drug development. • According to a report by the SAS Institute, enrollment strategies that leverage healthcare providers and pharmacies were the most effective in recruiting patients. • A strong research and healthcare network in a market enhances innovation and reduces risks of delays in clinical trials.

32%

30%

14%

120

14%

25

100

MSF

20

18%

80

26%

15

11%

60

# of Existing Hospitals

10

40

9%

48%

5

20

0

-

Dallas/Ft. Worth

Houston Hub Avg.

Secondary Avg.

Phoenix

Atlanta Indianapolis Austin Salt Lake City

Source: Cushman & Wakefield Research, Costar

*Hospitals considered top tier are those designated as 4- or 5-star buildings by Costar

41 41

Cushman & Wakefield